Pharmacokinetics of telbivudine in healthy subjects and absence of drug interaction with lamivudine or adefovir dipivoxil.
about
Safety and efficacy of telbivudine for the treatment of chronic hepatitis BAntiviral treatment of chronic hepatitis B virus (HBV) infectionsNonclinical safety profile of telbivudine, a novel potent antiviral agent for treatment of hepatitis BPharmacokinetics of telbivudine in subjects with various degrees of renal impairment.Telbivudine: a new option for the treatment of chronic hepatitis B.Treatment of chronic hepatitis B: focus on telbivudine.Treatment of HBeAg positive chronic hepatitis B: interferon or nucleoside analogues.Clinical features of adverse reactions associated with telbivudine.Absence of effect of telbivudine on cardiac repolarization: results of a thorough QT/QTc study in healthy participants.Single-dose and multiple-dose pharmacokinetics and safety of telbivudine after oral administration in healthy Chinese subjects.Telbivudine: a hepatitis B-specific antiviral.Population pharmacokinetics of telbivudine and determination of dose adjustment for patients with renal impairment.Determination of telbivudine in the plasma of chronic hepatitis B patients in long-term treatment by high-performance liquid chromatographic-tandem mass spectrometry.
P2860
Q28972486-3561166C-6FFC-42E5-B232-232D69B04198Q34223779-670A1BA1-9F88-47CE-8DC2-B980C5D33B45Q34591879-7048ABB9-9F53-41BE-9451-4008B7301269Q36313219-9EEFB1DD-BCF4-4C62-BE87-18C22B76BB61Q36810314-4AF64566-C626-48FE-BB03-1D6A78179612Q37432074-83144597-69CD-4EC1-9911-7A1EADD58ECDQ38071400-D9AE32D3-0BD4-48A3-9ABA-3BB77E366400Q41787869-7D64A99C-D4AF-4542-9ED0-929946CC9908Q43260525-25D28F85-3E7D-4543-9F03-D8FDF562ABCFQ43830802-ACEF3125-1F38-4ACB-A89B-37126D29E0A9Q45253502-BEFB8F01-5359-4D5A-9D92-D6326CC94281Q46036075-C4BF1602-A51B-4184-98D4-EC06F4ACB228Q48283573-0AD43A22-C6AB-41F1-B1D8-2DB0CF26B082
P2860
Pharmacokinetics of telbivudine in healthy subjects and absence of drug interaction with lamivudine or adefovir dipivoxil.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Pharmacokinetics of telbivudin ...... ivudine or adefovir dipivoxil.
@ast
Pharmacokinetics of telbivudin ...... ivudine or adefovir dipivoxil.
@en
Pharmacokinetics of telbivudin ...... ivudine or adefovir dipivoxil.
@nl
type
label
Pharmacokinetics of telbivudin ...... ivudine or adefovir dipivoxil.
@ast
Pharmacokinetics of telbivudin ...... ivudine or adefovir dipivoxil.
@en
Pharmacokinetics of telbivudin ...... ivudine or adefovir dipivoxil.
@nl
prefLabel
Pharmacokinetics of telbivudin ...... ivudine or adefovir dipivoxil.
@ast
Pharmacokinetics of telbivudin ...... ivudine or adefovir dipivoxil.
@en
Pharmacokinetics of telbivudin ...... ivudine or adefovir dipivoxil.
@nl
P2093
P2860
P356
P1476
Pharmacokinetics of telbivudin ...... ivudine or adefovir dipivoxil.
@en
P2093
Barbara A Fielman
Deborah M Lloyd
George C Chao
Nathaniel A Brown
Xiao-Jian Zhou
P2860
P304
P356
10.1128/AAC.01313-05
P407
P577
2006-07-01T00:00:00Z